Legal

Last Updated: Jan 20th, 2025

These Terms govern the BAT TESTING™ process and all associated services delivered through the BATWATCH™ ecosystem. By participating in any BAT TESTING™ services, you acknowledge and agree to the definitions, roles, responsibilities, and limitations set forth herein.

1. Who’s Who in the BATWATCH™ Program

“BATWATCH™” refers to an integrated system of affiliated legal and operational entities, including:

BATWatch Medical Group, LLC: A national management services organization (MSO) that provides infrastructure, digital systems, coordination protocols, and operational oversight. It does not deliver clinical services directly.

Affiliated Professional Corporations (PCs): State-licensed medical entities operating under the BATWATCH™ umbrella (e.g., BATWatch of California, PC), responsible for clinical services and telehealth delivery in their respective states.

BATWATCH™ Provider Network: Independent, licensed clinicians who engage in testing, interpretation, and protocol-guided care coordination.

BATWatch, Inc.: The parent IP-holding company and creator of BATWATCH™ protocols, scoring systems, and registry structures. It does not provide healthcare and is not a clinical entity.

Unless otherwise stated, references to “BATWATCH™” apply to this ecosystem as a whole, within each entity’s legally defined role.

2. Key Definitions

BAT TEST™: A proprietary, protocol-driven brain biomarker evaluation process that integrates validated lab assays for Beta-Amyloid and Tau. It is exclusive to the BATWATCH™ platform and includes clinician oversight, interpretive frameworks, and intervention guidance.

BAT TESTING™: The multi-phase clinical workflow within the BATWATCH™ protocol. It integrates third-party lab technology into a protected system of reflex testing, confirmation panels, and provider-reviewed recommendations.

BAT LEVELS™: A proprietary scoring and interpretation method for evaluating BA + Tau levels to quantify early biological drift.

BAT SCORE™: A 0–100 patient-facing score summarizing biological burden. The scoring algorithm is confidential and proprietary.

BAT PILL™ Protocol: A trademarked, clinician-guided short-cycle intervention using off-label autophagy activators (e.g., sirolimus) under strict supervision. Not a reference to a single pill or product.

CLEARANCE CHECK™ Panel: The final panel used post-intervention to confirm biomarker reduction and rule out rebound.

FACTOR MAPPING (FM): A lifestyle and risk screening layer identifying comorbid influences (e.g., inflammation, sleep, stress).

MECHANISM MAPPING™ (MM Panel): An optional diagnostic lab panel used to evaluate glymphatic, metabolic, hormonal, or mitochondrial contributors to biological drift.

Referring Provider: A licensed clinician who initiates a BAT TEST™ referral but may or may not manage downstream care.

Patient: Any individual who initiates, completes, or engages with BAT TESTING™ through the BATWATCH™ platform.

3. BAT TESTING™ Protocol Structure

BAT TESTING™ is a protected, multi-step sequence, not a single test. This design reduces false positives, ensures high specificity, and supports meaningful intervention only when appropriate.

Step 1: BA Test (Beta-Amyloid Panel)

Measures plasma Aβ42/40 ratios

Screens for early beta-amyloid accumulation

Step 2: Reflex Trigger

May trigger second BA Test (for confirmation)

Or Factor Check (BA retest + Tau + Glymphatic Risk Test)

Step 3: Pre-Protocol Readiness (Checkpoint Panel)

Screens patients for safety and readiness prior to BAT PILL™ initiation

Step 4: Post-Protocol Panels

CLEARANCE CHECK™ confirms biomarker reduction

MECHANISM MAPPING™ identifies upstream contributors

4. Why BATWATCH™ Uses Multiple Tests

Single-timepoint readings of BA/Tau are known to fluctuate due to:

Sleep quality

Stress and inflammation

Sample handling variability

To minimize clinical noise, BATWATCH™ uses:

Reflex testing to cross-verify

Confirmation panels to rule out transient spikes

Integrated scoring and timing windows

This system reduces false positives and avoids premature intervention.

5. Why Blood Testing is Superior for Ongoing Tracking

Spinal taps are invasive and not necessarily more accurate.

CSF and plasma biomarkers show similar drift patterns

Blood testing allows repeated tracking over time

Modern assays now offer AUCs >0.90

BATWATCH™ chooses blood-based diagnostics for prevention:

Lower risk, higher scalability

Repeatable annual tracking

Better suited for asymptomatic populations

6. Insurance, Lab Partnerships, and Financial Access

Some tests are covered by insurance; others may require pre-authorization

BATWATCH™ manages submissions and appeals

Cash-pay options are available if needed

BATWATCH™ does not sell lab tests or profit from labs directly

Lab partners must meet reproducibility and analyte accuracy thresholds

All labs are externally validated but must conform to BATWATCH™ protocol requirements to be eligible for inclusion.

7. Data Use, Privacy, and Clinical Oversight

a) Data Custodian
BATWATCH™ is the HIPAA-compliant custodian of all medical data associated with BAT TESTING™, including lab results, scoring history, and provider notes.

b) Result Access
Patients receive secure digital access to results. Referring and treating providers may access shared records, with appropriate patient authorization.

c) Shared Access with Referring Providers
Providers who initiate testing may receive summary reports and coordination notes. Final treatment decisions are governed by BATWATCH™ care teams unless otherwise delegated.

d) Research & Quality Improvement
De-identified, aggregated data may be used for internal R&D, registry analysis, and protocol improvement. No identifiable data is used without written patient consent.

e) Record Retention
All test results, coordination history, and risk scores are retained per federal recordkeeping and research documentation standards.

8. Proprietary Protections and Trade Secret Warning

The following components are proprietary and not subject to external access, discovery, or duplication:

BAT SCORE™ scaling system and calculation logic

Reflex test trigger rules and override algorithms

Intervention thresholds and step progression logic

BAT PILL™ dosage intervals, washout schedules, and eligibility scoring

MM Panel scoring weights and pathway prioritization

These systems are protected under U.S. trade secret law and BATWATCH™ reserves all rights. Any unauthorized use, reverse-engineering, or forced disclosure attempt is prohibited and will be challenged.